As Teva Wins U.S. Approval for GSK Advair Copy, Main Fight Yet to Come As Teva Wins U.S. Approval for GSK Advair Copy, Main Fight Yet to Come

Israel ' s Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline ' s best-selling Advair inhaler, although the real battle is still to come.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Alert Source Type: news